OTCMKTS:BIOQBIOQUAL Stock Price, Forecast & News

$72.00

0.00 (0.00 %)

(As of 05/26/2020 08:53 AM ET)

Add

Compare

Today's Range

$72.00

Now: $72.00▼

$72.00

50-Day Range

$63.00

MA: $70.75▼

$78.00

52-Week Range

$28.00

Now: $72.00▼

$78.00

VolumeN/A

Average Volume193 shs

Market Capitalization$64.08 million

P/E Ratio15.69

Dividend Yield0.97%

Beta-0.35

Bioqual, Inc. provides research, development, pre-clinical, consulting, and testing/assay services to commercial clients and government laboratories in the United States. The company provides research services in the areas of cancer, AIDS, hepatitis, influenza, immunology, transgenic, contraception, breeding and development of genetically defined animals, and neurobiology and behavior, as well as zika, dengue, malaria, respiratory syncytial virus, and other infectious diseases. Its services also include sample processing, virus stock generation, infectious virus quantitation, virus neutralization assays, hemagglutination inhibition assays, quantitative PCR, antigen and antibody ELISA detection assays, flow cytometry, lymphocyte proliferation, and other cell-based assays. In addition, the company provides in-vivo animal model related services. Bioqual, Inc. was founded in 1981 and is headquartered in Rockville, Maryland.

Beat the Market (BTM) Rank^™

0.0 Analyst's Opinion

Consensus Rating
There is not enough analysis data for BIOQUAL.

2.6 Community Rank

Outperform Votes
BIOQUAL has received 106 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
BIOQUAL has received 97 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
BIOQUAL has received 52.22% “outperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about BIOQUAL and other stocks. Vote “Outperform” if you believe BIOQ will outperform the S&P 500 over the long term. Vote “Underperform” if you believe BIOQ will underperform the S&P 500 over the long term. You may vote once every thirty days.

1.7 Dividend Strength

Dividend Leadership
BIOQUAL is a leading dividend payer. It pays a dividend yield of 0.97%, putting its dividend yield in the top 25% of dividend-paying stocks.
Dividend Growth
BIOQUAL does not have a long track record of dividend growth.

1.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, BIOQUAL insiders have not sold or bought any company stock.
Percentage Held by Insiders
39.24% of the stock of BIOQUAL is held by insiders. A high percentage of insider ownership can be a sign of company health.

0.6 Earnings and Valuation

Price to Earnings Ratio vs. the Market
The P/E ratio of BIOQUAL is 15.69, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 13.93.
Price to Earnings Ratio vs. Sector
The P/E ratio of BIOQUAL is 15.69, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 26.10.
Price to Book Value per Share Ratio
BIOQUAL has a P/B Ratio of 2.62. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Overall Beat the Market Rank^™

1.18 out of 5 stars

Industry, Sector and Symbol

Stock Exchange OTCMKTS

Industry Commercial physical research

Sub-IndustryN/A

SectorMedical

Current SymbolOTCMKTS:BIOQ

Previous Symbol

CUSIP09065J101

CIK719711

Webwww.bioqual.com

Phone240-404-7654

Debt

Debt-to-Equity RatioN/A

Current Ratio3.39

Quick Ratio3.39

Price-To-Earnings

Trailing P/E Ratio15.69

Forward P/E RatioN/A

P/E GrowthN/A

Sales & Book Value

Annual Sales$39.48 million

Price / Sales1.62

Cash Flow$4.14 per share

Price / Cash Flow17.39

Book Value$27.46 per share

Price / Book2.62

Profitability

EPS (Most Recent Fiscal Year)N/A

Net Income$2.83 million

Net Margins9.23%

Return on Equity16.16%

Return on Assets10.77%

Miscellaneous

EmployeesN/A

Outstanding Shares890,000

Market Cap$64.08 million

Next Earnings Date9/11/2020 (Estimated)

OptionableNot Optionable

Receive BIOQ News and Ratings via Email

Sign-up to receive the latest news and ratings for BIOQ and its competitors with MarketBeat's FREE daily newsletter.

BIOQUAL (OTCMKTS:BIOQ) Frequently Asked Questions

How has BIOQUAL's stock been impacted by COVID-19 (Coronavirus)?

BIOQUAL's stock was trading at $51.75 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, BIOQ stock has increased by 39.1% and is now trading at $72.00. View which stocks have been most impacted by Coronavirus.

When is BIOQUAL's next earnings date?

BIOQUAL is scheduled to release its next quarterly earnings announcement on Friday, September 11th 2020. View our earnings forecast for BIOQUAL.

How often does BIOQUAL pay dividends? What is the dividend yield for BIOQUAL?

BIOQUAL declared an annual dividend on Friday, September 13th. Shareholders of record on Wednesday, September 25th will be given a dividend of $0.70 per share on Wednesday, October 16th. This represents a yield of 2%. The ex-dividend date is Tuesday, September 24th. This is an increase from BIOQUAL's previous annual dividend of $0.60. View BIOQUAL's dividend history.

Has BIOQUAL been receiving favorable news coverage?

News headlines about BIOQ stock have been trending negative this week, according to InfoTrie Sentiment Analysis. The research group scores the sentiment of news coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. BIOQUAL earned a coverage optimism score of -2.6 on InfoTrie's scale. They also assigned news headlines about the company a news buzz of 9.0 out of 10, indicating that recent news coverage is extremely likely to have an effect on the stock's share price in the near term. View the latest news aboutBIOQUAL.

Who are some of BIOQUAL's key competitors?

Some companies that are related to BIOQUAL include Anavex Life Sciences (AVXL), Auxly Cannabis Group (CBWTF), Luna Innovations (LUNA), Pieris Pharmaceuticals (PIRS), Eloxx Pharmaceuticals (ELOX), Bioanalytical Systems (BASI), Cleveland BioLabs (CBLI), HedgePath Pharmaceuticals (HPPI), Tenax Therapeutics (TENX), Geovax Labs (GOVX), Vitality Biopharma (VBIO), US Stem Cell (USRM), Protalex (PRTX), ALGAE TEC LTD/S (ALGXY) and Redpoint Bio (RPBC). View all competitors.

Who are BIOQUAL's key executives?

BIOQUAL's management team includes the following people:

Dr. David A. Newcomer, Chief Financial Officer (Age 58)
Dr. Marisa St. Claire DVM, VP - Primate Biology and Medicine (Age 54)
Dr. Mark G. Lewis, Chairman, CEO & Pres (Age 64)
Mitch Franklin, Chief Operating Officer
Nancy A. Madden, VP of Admin. Operations & Biosafety Officer

What is BIOQUAL's stock symbol?

BIOQUAL trades on the OTCMKTS under the ticker symbol "BIOQ."

How do I buy shares of BIOQUAL?

Shares of BIOQ can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is BIOQUAL's stock price today?

One share of BIOQ stock can currently be purchased for approximately $72.00.

How big of a company is BIOQUAL?

BIOQUAL has a market capitalization of $64.08 million and generates $39.48 million in revenue each year.

What is BIOQUAL's official website?

The official website for BIOQUAL is www.bioqual.com.

How can I contact BIOQUAL?

BIOQUAL's mailing address is 9600 Medical Center Drive Suite 101, ROCKVILLE MD, 20850. The company can be reached via phone at 240-404-7654 or via email at [email protected]

This page was last updated on 5/26/2020 by MarketBeat.com Staff